UBS Group
BSTG

UBS Group’s Biostage, Inc. Common Stock BSTG Stock Holding History

UBS Group’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,565
Closed -$3K – 8433
2017
Q3 		$3K Sell
9,565
-1,000
-9% -$401 ﹤0.01% 7443
2017
Q2 		$4K Sell
10,565
-31,827
-75% -$10.1K ﹤0.01% 7257
2017
Q1 		$16K Buy
42,392
+6,608
+18% +$3.62K ﹤0.01% 6339
2016
Q4 		$32K Buy
35,784
+31,082
+661% +$27.7K ﹤0.01% 6197
2016
Q3 		$5K Buy
4,702
+3,945
+521% +$4.25K ﹤0.01% 7164
2016
Q2 		$1K Sell
757
-1,794
-70% -$2.89K ﹤0.01% 7625
2016
Q1 		$5K Sell
2,551
-1,903
-43% -$3.16K ﹤0.01% 7042
2015
Q4 		$10K Buy
4,454
+1,067
+32% +$1.49K ﹤0.01% 7313
2015
Q3 		$3K Buy
3,387
+2,430
+254% +$2.75K ﹤0.01% 7999
2015
Q2 		$1K Hold
957
– – ﹤0.01% 8377
2015
Q1 		$3K Sell
957
-849
-47% -$2.89K ﹤0.01% 8378
2014
Q4 		$6K Buy
+1,806
New +$8.95K ﹤0.01% 8897

UBS Group's BSTG Position: Q4 2017 in Review

UBS Group sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 9,565 shares — an estimated $3K sold.

UBS Group first reported a position in BSTG in Q4 2014 and held it in 12 quarters. The position peaked at $32K in Q4 2016. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

  • UBS Group reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • UBS Group sold 9,565 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $3K.
  • UBS Group first reported a position in Biostage, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
  • UBS Group's Biostage, Inc. Common Stock position peaked at $32K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.